Arrowhead Pharmaceuticals

About:

Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.

Website: http://arrowheadpharma.com/

Twitter/X: ArrowheadPharma

Top Investors: RA Capital Management, Sixth Street, OrbiMed, Silence Therapeutics, York Capital Management

Description:

Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.

Total Funding Amount:

$1.3B

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Pasadena, California, United States

Founded Date:

1989-01-01

Contact Email:

info(AT)arrowres.com

Founders:

R. Bruce Stewart

Number of Employees:

501-1000

Last Funding Date:

2024-08-08

IPO Status:

Public

© 2025 bioDAO.ai